2013 IFT International Food Nanoscience Conference: Proceedings: IFT Conference Proceedings…

Strategies to control mycotoxins and toxigenic fungi contamination by nano-semiconductor in food and agro-food: a review

Mycotoxins are toxic secondary metabolites generated from toxigenic fungi in the contaminated food and agro-food, which have been regarded as a serious threat to the food safety and human health. Therefore, the control of mycotoxins and toxigenic fungi contamination is of great significance and has attracted the increasing attention of researchers. As we know, nano-semiconductors have many unique properties such as large surface area, structural stability, good biocompatibility, excellent photoelectrical properties, and low cost, which have been developed and applied in many research fields. Recently, nano-semiconductors have also been promisingly applied in mitigating or controlling mycotoxins and toxigenic fungi contaminations in food and agro-food. In this review, the type, occurrence, and toxicity of main mycotoxins in food and agro-food were introduced. Then, a variety of strategies to mitigate the mycotoxin contamination based on nano-semiconductors involving mycotoxins detection, inhibition of toxigenic fungi, and mycotoxins degradation were summarized. Finally, the outlook, opportunities, and challenges have prospected in the future for the mitigation of mycotoxins and toxigenic fungi based on nano-semiconductors.

Progress and future of in vitro models to study translocation of nanoparticles

The increasing use of nanoparticles in products likely results in increased exposure of both workers and consumers. Because of their small size, there are concerns that nanoparticles unintentionally cross the barriers of the human body. Several in vivo rodent studies show that, dependent on the exposure route, time, and concentration, and their characteristics, nanoparticles can cross the lung, gut, skin, and placental barrier. This review aims to evaluate the performance of in vitro models that mimic the barriers of the human body, with a focus on the lung, gut, skin, and placental barrier. For these barriers, in vitro models of varying complexity are available, ranging from single-cell-type monolayer to multi-cell (3D) models. Only a few studies are available that allow comparison of the in vitro translocation to in vivo data. This situation could change since the availability of analytical detection techniques is no longer a limiting factor for this comparison. We conclude that to further develop in vitro models to be used in risk assessment, the current strategy to improve the models to more closely mimic the human situation by using co-cultures of different cell types and microfluidic approaches to better control the tissue microenvironments are essential. At the current state of the art, the in vitro models do not yet allow prediction of absolute transfer rates but they do support the definition of relative transfer rates and can thus help to reduce animal testing by setting priorities for subsequent in vivo testing.